Table 5.
Experimental treatment | |||||
---|---|---|---|---|---|
Items | 80 mg/kg ZnSO4 | 20 mg/kg MHA-Zn2 | 40 mg/kg MHA-Zn | 80 mg/kg MHA-Zn | P-Value |
Zn concentration of liver (mg/kg) | |||||
Week 59 to 62 | 81.27 ± 4.31a,b | 78.94 ± 5.19b | 86.27 ± 5.92a | 86.76 ± 6.72a | 0.032 |
Week 63 to 66 | 78.59 ± 5.56b,c | 75.94 ± 6.56c | 83.16 ± 3.26a,b | 84.74 ± 6.13a | 0.015 |
Week 67 to 70 | 76.27 ± 4.31a,b | 74.08 ± 4.20b | 81.28 ± 6.54a | 82.11 ± 7.13a | 0.035 |
Week 71 to 72 | 74.09 ± 4.34b | 73.94 ± 6.56b | 80.92 ± 3.75a | 81.29 ± 4.65a | 0.004 |
MT mRNA expression of liver | |||||
Week 72 | 1.00 ± 0.03c | 0.62 ± 0.07d | 2.45 ± 0.07b | 2.67 ± 0.04a | <0.001 |
1Data represent the means from 8 replicates per treatment. Values are the means ± SD.
2MHA-Zn: methionine hydroxy analog chelate zinc.
a–dMeans with different superscripts within the same row are significantly different (P < 0.05). MT: metallothionein.